The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  August 2014 Next
  • Frontiers in Medicinal Chemistry

    June 23-26, 2013   San Francisco, US

    Co-organised by the European Federation for Medicinal Chemistry and the Division of Medicinal Chemistry of ACS.

    Organizing Committee:

    Jeff Zablocki, Ph.D. (USA)
    Patrick M. Woster, Ph.D. (USA)
    Koen Augustyns, Ph.D. (Belgium)
    Anders Karlen (Sweden)
    Ulrich Stilz (Germany)

    Scientific Advisory Committee:

    Koen Augustyns (Belgium)
    Peter Bernstein (USA)
    Robert DeVita (USA)
    Richard A. Gibbs (USA)
    Anders Karlen (Sweden)
    John Macor (USA)
    Thomas Prisinzano (USA)
    Patrick M. Woster (USA)
    Ulrich Stilz (Germany)
    Wendy Young (USA)
    Jeff Zablocki (USA)

    Frontiers 2013 will take place in the historic Fairmont Hotel, located at 950 Mason St. on Nob Hill, in the heart of San Francisco. Central to the Financial District, Union Square, the Embarcadero and Fisherman's Wharf, the Fairmont Hotel is located at the only spot in San Francisco where each of the City's cable car lines meet.
    The scientific program for Frontiers 2013 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry.

    Session topic areas include:

    Antiviral Drug Design
    Advances in the Treatment of Inflammation
    Imaging, Biomarkers & Translational Research
    Antibody/Drug Conjugates
    Molecular Modeling and Structure-Based Design
    Emerging Topics

28 29 30 31 01 02 03
04 05 06 07 08 09 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31
01 02 03 04 05 06 07
All events   |  Future events

Job portal

Principal Scientist Medicinal Chemistry, AstraZeneca: Medicinal Chemistry, Cardiovascular and Metabolic Diseases iMed , Mölndal, Sweden
read more

Two PhD fellowships in medicinal chemistry/organic chemistry, University of Copenhagen: The Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, Copenhagen, Denmark
read more

research professor radiopharmaceutics, KU Leuven: Dep. Pharmaceutical and Pharmacological Sciences, Leuven, Leuven, Belgium
read more

Job portal page

Follow us on Twitter

Follow us on LinkedIn

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBentham ScienceBayerMerck